SACS
type: EnsemblDatabaseReference

ATXN1 DOWN in 'moderate Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.52025918615557
p value: 0.0481895315670107
refers to: 203231_s_at
refers to: ATXN1
t statistic: -5.18228677558948

CYP26B1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1415801450187
p value: 0.0498878648283495
refers to: CYP26B1
refers to: 219825_at
t statistic: -3.75520289535599

COL5A2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -2.13452773676512
p value: 0.0443483996906398
refers to: COL5A2
refers to: 221729_at
t statistic: -3.90541090173326

(Assay) Moderate 1025
type: Assay
identifier: Moderate 1025
has participant: A-AFFY-33

221086_s_at
type: EFO_0005072
part of: A-AFFY-33

SCN3A
type: EnsemblDatabaseReference

RFK
type: EnsemblDatabaseReference

PLCB1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.25630994569479
p value: 0.0479171878377118
refers to: PLCB1
refers to: 213222_at
t statistic: -3.82522897435564

AMFR
type: EnsemblDatabaseReference

(Sample) clinical information/Test:MiniMental Status Examination=20-26 (incipient Alzheimer's disease)
type: EFO_0000001
property type: clinical information
property value: Test:MiniMental Status Examination=20-26 (incipient Alzheimer's disease)

204337_at
type: EFO_0005072
part of: A-AFFY-33

KIAA0368
type: EnsemblDatabaseReference

(Assay) Severe 807
type: Assay
identifier: Severe 807
has participant: A-AFFY-33

PLCB1
type: EnsemblDatabaseReference

ANO3
type: EnsemblDatabaseReference

DZIP1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.04724606024125
p value: 0.0417254934400745
refers to: DZIP1
refers to: 204557_s_at
t statistic: -3.96804654032982

PLK2
type: EnsemblDatabaseReference

PPP3CA
type: EnsemblDatabaseReference

(Assay) Moderate 1037
type: Assay
identifier: Moderate 1037
has participant: A-AFFY-33

202018_s_at
type: EFO_0005072
part of: A-AFFY-33

214874_at
type: EFO_0005072
part of: A-AFFY-33

COL5A2
type: EnsemblDatabaseReference

EFR3A DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.15383411008188
p value: 0.0297086522365706
refers to: EFR3A
refers to: 212149_at
t statistic: -4.57334122705216

(Assay) Severe 872
type: Assay
identifier: Severe 872
has participant: A-AFFY-33

SERPINI1
type: EnsemblDatabaseReference

RGS4
type: EnsemblDatabaseReference

(Factor value) DISEASE/severe Alzheimer's disease
type: EFO_0000001
property type: DISEASE
property value: severe Alzheimer's disease

203680_at
type: EFO_0005072
part of: A-AFFY-33

210383_at
type: EFO_0005072
part of: A-AFFY-33

(Factor value) DISEASE/normal
type: EFO_0000761
property type: DISEASE
property value: normal

Analysis of 'moderate Alzheimer's disease' vs 'normal'
type: MicroarrayDifferentialExpressionAnalysis

RCAN2
type: EnsemblDatabaseReference

LTF
type: EnsemblDatabaseReference

(Factor value) DISEASE/incipient Alzheimer's disease
type: EFO_0000001
property type: DISEASE
property value: incipient Alzheimer's disease

SCN3A DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.11155449461075
p value: 0.038714862066781
refers to: SCN3A
refers to: 210432_s_at
t statistic: -4.05260783862085

ATXN1
type: EnsemblDatabaseReference

PPP3CA DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.07913291886211
p value: 0.0370940727929771
refers to: PPP3CA
refers to: 202457_s_at
t statistic: -4.12343804543526

LRP1B
type: EnsemblDatabaseReference

VSNL1
type: EnsemblDatabaseReference

AMFR DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.18685869852828
p value: 0.0398038871925234
refers to: AMFR
refers to: 202203_s_at
t statistic: -4.02788316336715

RFK DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.49568015470252
p value: 0.0372016575633503
refers to: RFK
refers to: 203224_at
t statistic: -4.11318599476219

PCSK2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.24958683076811
p value: 0.0473279579264834
refers to: 204869_at
refers to: PCSK2
t statistic: -3.83398402259435

FAM65B DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.14109532358538
p value: 0.0301735383976893
refers to: FAM65B
refers to: 209829_at
t statistic: -4.54300115416938

209897_s_at
type: EFO_0005072
part of: A-AFFY-33

LDB2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.52378227446129
p value: 0.0145280439439383
refers to: LDB2
refers to: 206481_s_at
t statistic: -5.48488895835828

(Assay) Incipient 1019
type: Assay
identifier: Incipient 1019
has participant: A-AFFY-33

TRIM36
type: EnsemblDatabaseReference

A-AFFY-33
type: EFO_0000269

Analysis of 'severe Alzheimer's disease' vs 'normal'
type: MicroarrayDifferentialExpressionAnalysis

LRP1B DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.0426896197064
p value: 0.0343588516114728
refers to: LRP1B
refers to: 219643_at
t statistic: -4.28215183261262

CNR1
type: EnsemblDatabaseReference

(Assay) Incipient 994
type: Assay
identifier: Incipient 994
has participant: A-AFFY-33

(Assay) Control 1040
type: Assay
identifier: Control 1040
has participant: A-AFFY-33

205030_at
type: EFO_0005072
part of: A-AFFY-33

PTPRN2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.05097630256768
p value: 0.0485268463623287
refers to: PTPRN2
refers to: 203029_s_at
t statistic: -3.79960322105193

ETV1
type: EnsemblDatabaseReference

213222_at
type: EFO_0005072
part of: A-AFFY-33

NETO2
type: EnsemblDatabaseReference

CNR1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.98621996424768
p value: 0.0346386192105658
refers to: CNR1
refers to: 213436_at
t statistic: -4.25231343875792

RALYL DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.17927403717515
p value: 0.0330358301331387
refers to: 213967_at
refers to: RALYL
t statistic: -4.37028446724222

(Assay) Incipient 1043
type: Assay
identifier: Incipient 1043
has participant: A-AFFY-33

SERPINI1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.56225771548935
p value: 0.0398038871925234
refers to: SERPINI1
refers to: 205352_at
t statistic: -4.03051543606265

PLCB1
type: EnsemblDatabaseReference

RCAN2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.15787352737444
p value: 0.0346386192105658
refers to: RCAN2
refers to: 203498_at
t statistic: -4.24984504306063

PRKCB DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.87664797473065
p value: 0.0398038871925234
refers to: PRKCB
refers to: 207957_s_at
t statistic: -4.0229901337981

CLDN10 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.06126944461835
p value: 0.0179713816589585
refers to: CLDN10
refers to: 205328_at
t statistic: -5.13249407231645

ITM2A DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10789027693848
p value: 0.0338825184433273
refers to: 202746_at
refers to: ITM2A
t statistic: -4.30244460866345

PLK2
type: EnsemblDatabaseReference

RB1CC1
type: EnsemblDatabaseReference

PRKAR2B
type: EnsemblDatabaseReference

(Sample) organism part/hippocampus
type: EFO_0000530
property type: organism part
property value: hippocampus

205328_at
type: EFO_0005072
part of: A-AFFY-33

FAM65B
type: EnsemblDatabaseReference

COL5A2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.95417738741605
p value: 0.0376814736999223
refers to: COL5A2
refers to: 221730_at
t statistic: -4.08993424482153

DZIP1
type: EnsemblDatabaseReference

TRIM36 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.42662252956753
p value: 0.0305752160089241
refers to: TRIM36
refers to: 219736_at
t statistic: -4.47282937719234

PTPRN2
type: EnsemblDatabaseReference

203797_at
type: EFO_0005072
part of: A-AFFY-33

COL5A2
type: EnsemblDatabaseReference

212149_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Control 1008
type: Assay
identifier: Control 1008
has participant: A-AFFY-33

ITM2A
type: EnsemblDatabaseReference

RCAN2
type: EnsemblDatabaseReference

SACS
type: EnsemblDatabaseReference

PLK2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.67920511812153
p value: 0.0365049465566842
refers to: PLK2
refers to: 201939_at
t statistic: -4.16348611683619

215241_at
type: EFO_0005072
part of: A-AFFY-33

204557_s_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Control 1039
type: Assay
identifier: Control 1039
has participant: A-AFFY-33

(Sample) clinical information/minimental Status Examination
type: EFO_0000001
property type: clinical information
property value: minimental Status Examination

213262_at
type: EFO_0005072
part of: A-AFFY-33

CACNG3
type: EnsemblDatabaseReference

205352_at
type: EFO_0005072
part of: A-AFFY-33

212428_at
type: EFO_0005072
part of: A-AFFY-33

205113_at
type: EFO_0005072
part of: A-AFFY-33

SATB2
type: EnsemblDatabaseReference

RFK
type: EnsemblDatabaseReference

(Factor value) DISEASE/moderate Alzheimer's disease
type: EFO_0000001
property type: DISEASE
property value: moderate Alzheimer's disease

KIAA0368
type: EnsemblDatabaseReference

218888_s_at
type: EFO_0005072
part of: A-AFFY-33

205691_at
type: EFO_0005072
part of: A-AFFY-33

ANO3
type: EnsemblDatabaseReference

CYP26B1
type: EnsemblDatabaseReference

211737_x_at
type: EFO_0005072
part of: A-AFFY-33

206384_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Moderate 1031
type: Assay
identifier: Moderate 1031
has participant: A-AFFY-33

204869_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Incipient 715
type: Assay
identifier: Incipient 715
has participant: A-AFFY-33

PRKCB
type: EnsemblDatabaseReference

205489_at
type: EFO_0005072
part of: A-AFFY-33

TRIM36
type: EnsemblDatabaseReference

209829_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Incipient 720
type: Assay
identifier: Incipient 720
has participant: A-AFFY-33

ETV1
type: EnsemblDatabaseReference

SCN1A DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.2270712811862
p value: 0.0328484704726226
refers to: SCN1A
refers to: 210383_at
t statistic: -4.37984888824666

(Assay) Control 1015
type: Assay
identifier: Control 1015
has participant: A-AFFY-33

(Assay) Severe 701
type: Assay
identifier: Severe 701
has participant: A-AFFY-33

NETO2
type: EnsemblDatabaseReference

221730_at
type: EFO_0005072
part of: A-AFFY-33

(Sample) clinical information/Test:MiniMental Status Examination=14-19 (moderate Alzheimer's disease)
type: EFO_0000001
property type: clinical information
property value: Test:MiniMental Status Examination=14-19 (moderate Alzheimer's disease)

(Assay) Moderate 965
type: Assay
identifier: Moderate 965
has participant: A-AFFY-33

CRYM
type: EnsemblDatabaseReference

RGS7
type: EnsemblDatabaseReference

203231_s_at
type: EFO_0005072
part of: A-AFFY-33

VSNL1
type: EnsemblDatabaseReference

Homo sapiens
type: OBI_0100026

206481_s_at
type: EFO_0005072
part of: A-AFFY-33

EFR3A
type: EnsemblDatabaseReference

PCSK2
type: EnsemblDatabaseReference

213436_at
type: EFO_0005072
part of: A-AFFY-33

NEFM
type: EnsemblDatabaseReference

MAP3K9
type: EnsemblDatabaseReference

213927_at
type: EFO_0005072
part of: A-AFFY-33

FEZF2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.11393022576777
p value: 0.0498878648283495
refers to: FEZF2
refers to: 221086_s_at
t statistic: -3.75477183723227

(Sample) disease/severe Alzheimer's disease
type: EFO_0000001
property type: disease
property value: severe Alzheimer's disease

ETV1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.50370841162278
p value: 0.0166769856176087
refers to: ETV1
refers to: 221911_at
t statistic: -5.25302275821005

(Assay) Severe 819
type: Assay
identifier: Severe 819
has participant: A-AFFY-33

SCN1A
type: EnsemblDatabaseReference

(Assay) Moderate 856
type: Assay
identifier: Moderate 856
has participant: A-AFFY-33

RB1CC1
type: EnsemblDatabaseReference

PRKAR2B
type: EnsemblDatabaseReference

(Sample) disease/normal
type: EFO_0000761
property type: disease
property value: normal

202033_s_at
type: EFO_0005072
part of: A-AFFY-33

VSNL1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.5757936307603
p value: 0.0346776218914271
refers to: 203797_at
refers to: VSNL1
t statistic: -4.24100711396306

(Sample) disease/incipient Alzheimer's disease
type: EFO_0000001
property type: disease
property value: incipient Alzheimer's disease

FAM65B
type: EnsemblDatabaseReference

CRYM DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.42261157246832
p value: 0.0247279431029079
refers to: 205489_at
refers to: CRYM
t statistic: -4.72135287780079

(Sample) organism/Homo sapiens
type: Homo sapiens
property type: organism
property value: Homo sapiens

PTPRN2
type: EnsemblDatabaseReference

(Assay) Control 1003
type: Assay
identifier: Control 1003
has participant: A-AFFY-33

ITM2A
type: EnsemblDatabaseReference

SYNGR3
type: EnsemblDatabaseReference

LDB2
type: EnsemblDatabaseReference

SHANK2
type: EnsemblDatabaseReference

(Assay) Severe 1036
type: Assay
identifier: Severe 1036
has participant: A-AFFY-33

CACNG3
type: EnsemblDatabaseReference

206290_s_at
type: EFO_0005072
part of: A-AFFY-33

PTN
type: EnsemblDatabaseReference

CLDN10
type: EnsemblDatabaseReference

NETO2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.21654353590786
p value: 0.0338825184433273
refers to: 218888_s_at
refers to: NETO2
t statistic: -4.29457457621548

(Assay) Control 1018
type: Assay
identifier: Control 1018
has participant: A-AFFY-33

SATB2
type: EnsemblDatabaseReference

219825_at
type: EFO_0005072
part of: A-AFFY-33

CYP26B1
type: EnsemblDatabaseReference

FRY
type: EnsemblDatabaseReference

219643_at
type: EFO_0005072
part of: A-AFFY-33

FRY DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.15141152348292
p value: 0.0351977772283988
refers to: FRY
refers to: 204072_s_at
t statistic: -4.22169958236093

221729_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Severe 723
type: Assay
identifier: Severe 723
has participant: A-AFFY-33

202746_at
type: EFO_0005072
part of: A-AFFY-33

FABP7
type: EnsemblDatabaseReference

213967_at
type: EFO_0005072
part of: A-AFFY-33

PRKAR2B DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.34453754819713
p value: 0.0338825184433273
refers to: 203680_at
refers to: PRKAR2B
t statistic: -4.35125822785576

COL5A2 DOWN in 'moderate Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -2.18613183114725
p value: 0.0481895315670107
refers to: COL5A2
refers to: 221730_at
t statistic: -5.58093268285638

SLIT2
type: EnsemblDatabaseReference

201939_at
type: EFO_0005072
part of: A-AFFY-33

ANO3 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.52272855070102
p value: 0.0434147077480024
refers to: ANO3
refers to: 215241_at
t statistic: -3.9255277116879

CRYM
type: EnsemblDatabaseReference

202457_s_at
type: EFO_0005072
part of: A-AFFY-33

EFR3A
type: EnsemblDatabaseReference

NEFM
type: EnsemblDatabaseReference

PCSK2
type: EnsemblDatabaseReference

NEFH DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.52371773863363
p value: 0.0443483996906398
refers to: NEFH
refers to: 33767_at
t statistic: -3.90681104292581

204072_s_at
type: EFO_0005072
part of: A-AFFY-33

RGS7
type: EnsemblDatabaseReference

SLIT2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.10510378175924
p value: 0.0317925558305579
refers to: 209897_s_at
refers to: SLIT2
t statistic: -4.41819974376216

203224_at
type: EFO_0005072
part of: A-AFFY-33

SCN1A
type: EnsemblDatabaseReference

(Assay) Moderate 832
type: Assay
identifier: Moderate 832
has participant: A-AFFY-33

203029_s_at
type: EFO_0005072
part of: A-AFFY-33

MAP3K9
type: EnsemblDatabaseReference

207957_s_at
type: EFO_0005072
part of: A-AFFY-33

NEFM DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.72504892272159
p value: 0.0346386192105658
refers to: NEFM
refers to: 205113_at
t statistic: -4.26492492577087

PPP3CA
type: EnsemblDatabaseReference

PRKCB
type: EnsemblDatabaseReference

PKP4
type: EnsemblDatabaseReference

(Assay) Control 976
type: Assay
identifier: Control 976
has participant: A-AFFY-33

PTN DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.01953469268859
p value: 0.0144322899198522
refers to: PTN
refers to: 211737_x_at
t statistic: -6.11186113786469

SACS DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.13409635280694
p value: 0.0413679731805654
refers to: SACS
refers to: 213262_at
t statistic: -3.98391102887962

LDB2
type: EnsemblDatabaseReference

NEFH
type: EnsemblDatabaseReference

MAP3K9 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.13778744340352
p value: 0.0240939130550902
refers to: MAP3K9
refers to: 213927_at
t statistic: -4.77985418096721

(Sample) disease/moderate Alzheimer's disease
type: EFO_0000001
property type: disease
property value: moderate Alzheimer's disease

SYNGR3
type: EnsemblDatabaseReference

FEZF2
type: EnsemblDatabaseReference

SATB2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29965963428591
p value: 0.0418210328903632
refers to: SATB2
refers to: 213435_at
t statistic: -3.95669691645575

SERPINI1
type: EnsemblDatabaseReference

(Assay) Incipient 1029
type: Assay
identifier: Incipient 1029
has participant: A-AFFY-33

210432_s_at
type: EFO_0005072
part of: A-AFFY-33

221911_at
type: EFO_0005072
part of: A-AFFY-33

RALYL
type: EnsemblDatabaseReference

213308_at
type: EFO_0005072
part of: A-AFFY-33

SHANK2
type: EnsemblDatabaseReference

33767_at
type: EFO_0005072
part of: A-AFFY-33

LTF
type: EnsemblDatabaseReference

PTN
type: EnsemblDatabaseReference

SCN3A
type: EnsemblDatabaseReference

RGS7 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.40045483963084
p value: 0.0377300065461099
refers to: RGS7
refers to: 206290_s_at
t statistic: -4.0726529412541

SHANK2 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.03613311088256
p value: 0.0273584739472699
refers to: SHANK2
refers to: 213308_at
t statistic: -4.62215211386089

AMFR
type: EnsemblDatabaseReference

E-GEOD-1297
type: microarray 1colour mrna differential
RO_0002162: Homo sapiens
description: For these data, we analyzed hippocampal gene expression of nine control and 22 AD subjects of varying severity on 31 separate microarrays. We then tested the correlation of each gene's expression with MiniMental Status Examination (MMSE) and neurofibrillary tangle (NFT) scores across all 31 subjects regardless of diagnosis. These tests revealed a major transcriptional response comprising thousands of genes significantly correlated with AD markers. Several hundred of these genes were also correlated with AD markers across only control and incipient AD subjects (MMSE > 20).
uses data from: http://identifiers.org/pubmed/14769913

(Sample) clinical information/Test:MiniMental Status Examination=< 14 (severe Alzheimer's disease)
type: EFO_0000001
property type: clinical information
property value: Test:MiniMental Status Examination=< 14 (severe Alzheimer's disease)

213435_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) Control 1030
type: Assay
identifier: Control 1030
has participant: A-AFFY-33

(Assay) Moderate 826
type: Assay
identifier: Moderate 826
has participant: A-AFFY-33

(Assay) Severe 867
type: Assay
identifier: Severe 867
has participant: A-AFFY-33

RGS4 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.71111562350568
p value: 0.0372016575633503
refers to: RGS4
refers to: 204337_at
t statistic: -4.11394843806988

SLIT2
type: EnsemblDatabaseReference

RGS4
type: EnsemblDatabaseReference

RB1CC1 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.1890214304022
p value: 0.0169811460134873
refers to: 202033_s_at
refers to: RB1CC1
t statistic: -5.2216917427637

202203_s_at
type: EFO_0005072
part of: A-AFFY-33

SYNGR3 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.47269160150479
p value: 0.0302845121321101
refers to: SYNGR3
refers to: 205691_at
t statistic: -4.50369157530963

(Assay) Control 1012
type: Assay
identifier: Control 1012
has participant: A-AFFY-33

ATXN1
type: EnsemblDatabaseReference

LRP1B
type: EnsemblDatabaseReference

CLDN10
type: EnsemblDatabaseReference

LTF UP in 'severe Alzheimer's disease' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 1.50976928268883
p value: 0.0273584739472699
refers to: 202018_s_at
refers to: LTF
t statistic: 4.62178962519862

CACNG3 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.36917502018262
p value: 0.0144322899198522
refers to: CACNG3
refers to: 206384_at
t statistic: -5.93496890280082

219736_at
type: EFO_0005072
part of: A-AFFY-33

KIAA0368 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.29751246439349
p value: 0.0346386192105658
refers to: KIAA0368
refers to: 212428_at
t statistic: -4.25793998769216

(Assay) Incipient 1034
type: Assay
identifier: Incipient 1034
has participant: A-AFFY-33

FRY
type: EnsemblDatabaseReference

(Assay) Moderate 1020
type: Assay
identifier: Moderate 1020
has participant: A-AFFY-33

PKP4
type: EnsemblDatabaseReference

DZIP1
type: EnsemblDatabaseReference

203498_at
type: EFO_0005072
part of: A-AFFY-33

PKP4 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.074880758468
p value: 0.0366760968738687
refers to: PKP4
refers to: 214874_at
t statistic: -4.14222416527565

FABP7
type: EnsemblDatabaseReference

NEFH
type: EnsemblDatabaseReference

FEZF2
type: EnsemblDatabaseReference

RALYL
type: EnsemblDatabaseReference

CNR1
type: EnsemblDatabaseReference

FABP7 DOWN in 'severe Alzheimer's disease' vs 'normal'
type: DecreasedDifferentialExpressionRatio
fold change: -1.04938533825668
p value: 0.0485268463623287
refers to: FABP7
refers to: 205030_at
t statistic: -3.8121209764599